<DOC>
	<DOCNO>NCT01124760</DOCNO>
	<brief_summary>The aim study examine effect coadministration CYP3A4 inhibitor pharmacokinetics AZD9742 .</brief_summary>
	<brief_title>Open Label Study , Assessing Effect Diltiazem Ketoconazole Pharmacokinetics AZD9742 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Cytochrome P-450 CYP3A Inhibitors</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<criteria>nonchildbearing potential , suitable vein cannulation repeat venipuncture Females must negative pregnancy test screen admission unit , must lactate must nonchildbearing potential , confirm screening . Male volunteer willing use barrier contraception , ie , condom , day dose 3 month dose investigational product . History clinically significant disease disorder , opinion Investigator , may either put volunteer risk participation study , influence result volunteer 's ability participate History presence GI , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug judge Investigator . Any clinically significant illness , medical/surgical procedure , trauma within 4 week first administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>open label</keyword>
	<keyword>2-consecutive-group</keyword>
	<keyword>2-period</keyword>
	<keyword>1-sequence crossover study</keyword>
</DOC>